China Companion Animal Health Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

China Companion Animal Health Market is Segmented by Products (Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medicinal Feed Additives, and Other Therapeutics) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, and Other Diagnostics)) and Animal Type (Dogs and Cats, Horses, and Other Companion Animals). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

China Companion Animal Health Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

China Companion Animal Health Market Size

China Companion Animal Health Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 1.09 Billion
Market Size (2030) USD 1.37 Billion
CAGR (2025 - 2030) 4.69 %

Major Players

China Companion Animal Health Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of China Companion Animal Health Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

China Companion Animal Health Market Analysis

The China Companion Animal Health Market size is estimated at USD 1.09 billion in 2025, and is expected to reach USD 1.37 billion by 2030, at a CAGR of 4.69% during the forecast period (2025-2030).

Supply disruptions and shortages of veterinary medicines were observed in China, primarily due to the temporary lockdowns of manufacturing sites and increased demand for medicine to treat COVID-19. An article published in the Journal of Animals in July 2021 indicated that during the lockdown imposed on the COVID-19 pandemic, people were forced to leave their pets behind, significantly affecting the market's growth.

Also, some organizations in China announced campaigns to kill any cats or dogs found outdoors to prevent disease transmission. Such activities affecting the lives of pet animals drastically affected the growth of the companion animal health market in the nation during the COVID-19 pandemic. However, the market has recovered, and demand for companion health services has increased as the number of pet adoptions increased during the pandemic. Moreover, the market is expected to grow to its full potential over the forecast period.

The Chinese companion animal health market is primarily driven by the rising popularity of pet ownership, growing spending on animal healthcare, and rising awareness regarding the various treatments available for companion animal diseases.

In recent years, there has been a significant increase in the adoption of dogs and cats in China, as they are the favorite companions of human beings. According to the article published in Sixth Tone in August 2022, there were more than 58 million pet cats in China in 2021, an increase of 19.4% from the previous year, while there were 54 million pet dogs in 2021. With the increase in the number of companion animals, owners are becoming increasingly aware of their pet's health and nutrition and are also seeking veterinary services. This, in turn, is creating a growing demand for companion animal healthcare products, thereby boosting the market growth.

Furthermore, there are also increasing initiatives by the government and animal welfare associations to create awareness about the various diseases that affect companion animals, which will augment the growth of the market as awareness can prevent various animal-related diseases. For instance, in April 2022, "Empowering 10,000 China Pet Retailers" was an initiative that was started by the China International Pet Show (CIPS) to create awareness about companion animal medicines. By the end of 2022, the team had held 200 seminars, events, and training sessions in six different cities. This is expected to create awareness among pet retailers about companion medicine products, which are expected to drive the growth of the Chinese veterinary healthcare market. 

Additionally, rising public organization initiatives in China to educate people about the adoption of stray animals are expected to drive the growth of the Chinese veterinary healthcare market. For instance, in June 2021, Animal Rights Organisations in China opened a new welfare center to educate the public about animals and encourage the adoption of stray animals, even though no laws exist to protect them. This will further be expected to drive growth in taking care of stray animals, thereby boosting this market.

In addition, the growing investments in the development of manufacturing plants for pet care products are also one of the key contributors to the growth of the Chinese companion animal health market. For instance, in February 2021, Delvigent opened its new feed additive plant in China. The first phase of the state-of-the-art factory has a capacity of 60,000 metric tonnes per year for the production of feed additives with short- and medium-chain fatty acids and essential oils as main components, with the possibility to expand to 120,000 metric tonnes of feed additives per year in the future.

Thus, all the aforementioned factors, such as the growing adoption of pet animals and the launch of awareness initiatives and strategic activities by the market players, are expected to boost market growth over the forecast period. However, the availability of a considerable number of counterfeit animal products and drugs on the market, including several fakes or copied companion animal drugs, is identified as an obstruction to the growth of the Chinese companion animal health market.

China Companion Animal Health Industry Overview

The China companion animal health market is a consolidated market with few dominant players. The market players adopt various strategies such as product launches, mergers and acquisitions, and partnerships to stay competitive in the market. Key market players in the market include China Animal Husbandry Co. Ltd, Shenyang Dachang Medical Imaging Technology Co., Ltd., Elanco Animal Health, Merck & Co., Vetoquinol SA, Virbac, and Zoetis Inc., among others.

China Companion Animal Health Market Leaders

  1. Elanco Animal Health

  2. Merck & Co.

  3. Virbac

  4. Zoetis Inc.

  5. IDEXX Laboratories, Inc

  6. *Disclaimer: Major Players sorted in no particular order
China Companion Animal Health Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

China Companion Animal Health Market News

  • March 2023: i-Tail Corporation PCL reported an exclusivity contract with Nanjing Jiabei PetCare Products Co., Ltd, an importer and distributor of pet care products. The partnership is key in supporting the growth of ITC's business in China.
  • July 2022: JD Health acquired a pet care business pertaining to the purchase of pet health product categories, including prescription drugs/ prescription diet, pet nutrition, pet deworming, pet milk powder, pet mouth, ear and eye cleaning, and more.

China Companion Animal Health Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Pet Adoption in China
    • 4.2.2 Increasing Initiatives by the Governments and Animal Welfare Associations
    • 4.2.3 Advanced Technology in Animal Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Use of Counterfeit Medicines
    • 4.3.2 Increasing Costs of Animal Testing and Veterinary Care
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD)

  • 5.1 By Products
    • 5.1.1 Therapeutics
    • 5.1.1.1 Vaccines
    • 5.1.1.2 Parasiticides
    • 5.1.1.3 Anti Infectives
    • 5.1.1.4 Medicated Feed Additives
    • 5.1.1.5 Other Therapeutics
    • 5.1.2 Diagnostics
    • 5.1.2.1 Immunodiagnostic Tests
    • 5.1.2.2 Molecular Diagnostics
    • 5.1.2.3 Diagnostic Imaging
    • 5.1.2.4 Other Diagnostics
  • 5.2 By Animal Type
    • 5.2.1 Dogs
    • 5.2.2 Cats
    • 5.2.3 Horses
    • 5.2.4 Other Companion Animals

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 China Animal Husbandry Co. Ltd
    • 6.1.2 Shenyang Dachang Medical Imaging Technology Co., Ltd.
    • 6.1.3 Elanco Animal Health
    • 6.1.4 Merck & Co.
    • 6.1.5 Vetoquinol SA
    • 6.1.6 Virbac
    • 6.1.7 Zoetis Inc.
    • 6.1.8 IDEXX Laboratories Inc.
    • 6.1.9 Ceva Santé Animale
    • 6.1.10 Pulike Biological Engineering
    • 6.1.11 Tianjin Ringpu Biotechnology Co. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Companion Animal Health Industry Segmentation

Companion animals provide companionship to human beings, as well as guard their houses and offices. Currently, the various types of health diseases in animals have increased the demand for vaccines and diagnostic tests. This surge in demand is primarily due to the need to treat and cure a variety of diseases associated with the health of cats and dogs.

The China companion animal health market is segmented by products (therapeutics (vaccines, parasiticides, anti-infectives, medicated feed additives, and other therapeutics) and diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and other diagnostics)) and animal type (dogs, cats, horses, and other companion animals).

The report offers the value in USD for the above segments.

By Products Therapeutics Vaccines
Parasiticides
Anti Infectives
Medicated Feed Additives
Other Therapeutics
Diagnostics Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Other Diagnostics
By Animal Type Dogs
Cats
Horses
Other Companion Animals
Need A Different Region or Segment?
Customize Now

China Companion Animal Health Market Research FAQs

How big is the China Companion Animal Health Market?

The China Companion Animal Health Market size is expected to reach USD 1.09 billion in 2025 and grow at a CAGR of 4.69% to reach USD 1.37 billion by 2030.

What is the current China Companion Animal Health Market size?

In 2025, the China Companion Animal Health Market size is expected to reach USD 1.09 billion.

Who are the key players in China Companion Animal Health Market?

Elanco Animal Health, Merck & Co., Virbac, Zoetis Inc. and IDEXX Laboratories, Inc are the major companies operating in the China Companion Animal Health Market.

What years does this China Companion Animal Health Market cover, and what was the market size in 2024?

In 2024, the China Companion Animal Health Market size was estimated at USD 1.04 billion. The report covers the China Companion Animal Health Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Companion Animal Health Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

China Companion Animal Health Industry Report

Statistics for the 2025 China Companion Animal Health market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Companion Animal Health analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.